SCHEMBL657072

SCHEMBL657072

CCOC(=O)C(C(=O)OCC)C(CC(=O)c1ccc2cc(OC)ccc2c1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
CYP1A2 P05177 1/20 0.51
HPGD P15428 1/20 0.51
CYP2C19 P33261 1/20 0.51
HSD17B10 Q99714 1/20 0.51
KDM4E B2RXH2 1/20 0.48
MGAM O43451 1/20 0.46
GAA P10253 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
KMT2A Q03164 1/20 0.45
AKR1C3 P42330 4/20 0.44
AKR1C2 P52895 4/20 0.44
PTGS1 P23219 2/20 0.44
AKR1C1 Q04828 1/20 0.44
PDPK1 O15530 3/20 0.44
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656638 0.90 PDPK1 (0.53) ALDH1A1HPGDKDM4EMGAMGAA
SCHEMBL657537 0.88 PDPK1 (0.56) ALDH1A1CYP1A2HPGDCYP2C19HSD17B10
SCHEMBL656362 0.88 ALDH1A1 (0.48) ALDH1A1CYP1A2HPGDCYP2C19HSD17B10
SCHEMBL657566 0.85 ALDH1A1 (0.46) ALDH1A1CYP1A2HPGDCYP2C19HSD17B10
SCHEMBL657387 0.84 PDPK1 (0.58) ALDH1A1HPGDKDM4EMGAMGAA
SCHEMBL657195 0.84 PDPK1 (0.49) ALDH1A1HPGDKDM4EMGAMGAA
SCHEMBL658086 0.82 NPC1 (0.54) ALDH1A1HPGDL3MBTL1MEN1NPC1
SCHEMBL5448457 0.81 ALDH1A1 (0.51) ALDH1A1CYP1A2HPGDCYP2C19HSD17B10
SCHEMBL7109210 0.81 KMT2A (0.67) ALDH1A1CYP1A2HPGDCYP2C19KDM4E
SCHEMBL657980 0.79 ALDH1A1 (0.48) ALDH1A1CYP1A2HPGDCYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB ALDH1A1 4784/4885CYP1A2 4611/4885HPGD 4359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.